TSE:CSU

Constellation Software Inc. (CSU.TO)

2,855.53
+53.39 (1.91%)
as of Jul 13, 2026, 8:00:00 pm Market Open.
636 watching
0
Investor Insights
star iconJul 13, 2026, 12:00 am

This summary was created by AI, based on 86 opinions in the last 12 months.

Constellation Software Inc. (CSU) has faced significant challenges recently, particularly concerning the departure of its long-serving CEO, Mark Leonard, and increasing fears about AI's potential disruption of traditional software businesses. Many analysts believe the company's strong acquisition model and established market presence position it well for future growth, although concerns about its ability to sustain its roll-up strategy persist, especially in light of competitive pressures and market sentiment around software. The consensus from various experts suggests that while the current valuation is attractive, especially compared to historical levels, caution is advised given the potential for continued volatility and the need for the company to demonstrate sustained organic growth. Overall, despite the mixed sentiments regarding its immediate future, a substantial number of analysts remain bullish on CSU's long-term growth prospects, reflecting confidence in its business model and management team.

consensus icon
Consensus
Mixed
valuation icon
Valuation
Undervalued
review icon
Similar
Shopify,SHOP
BUY ON WEAKNESS

Good long term investment, but stock too expensive at current price. Wait for weakness in share price before investing. Excellent management team that is good at capital allocation. 

BUY ON WEAKNESS

Share price over the 200 day moving average (not good for investors). Good business, but would wait for weakness before buying. Stock price overvalued. 

BUY ON WEAKNESS

Unique business model that you can't easily replicate in the spinoffs. Valuation a bit rich at over 30x cashflow. Eventually, will be some volatility and you'll get your change to buy more. Exceptionally high growth despite its size. One of the best compounders ever created, not just in Canada but globally.

BUY ON WEAKNESS

Very good company. Owns shares in portfolio. Currently trading at reasonable price to growth level. Would wait for share price to fall before buying. Excellent management team with strong tech stack. 

BUY
CSU vs. TOI vs. LMN.

CSU still owns 61% of Lumina, so they're still driving the bus. Lumina geared towards media side. LMN is supposed to be the mini-Constellation. 

CSU has gone through its price target. LMN is under its price target. So LMN is probably a little cheaper.

He'd invest in all 3. Say you had $100K. He'd put 60% in CSU, and split the rest between TOI and LMN.

TOP PICK

They acquire tech companies, granting those companies freedom to operate. They operate in an tight-lipped, unorthodox manner, like they don't host conference calls. But they compounded earnings at 2% over the past decade. Trades at 20x earnings.

(Analysts’ price target is $3273.33)
BUY ON WEAKNESS

Largest position in portfolio(~14%). Excellent company. One of the best compounders in the world. Roll up strategy of software. Founder led and owned. Only problem is that stock is expensive. Good for long term investors. Very strong management team. Able to re-invest 100% of cash flow into M&A. 

HOLD
Sell or hold in face of price volatility?

You have the Magnificent 7 south of the border. This is Canada's Magnificent 1. Slow and steady. Acquires at good prices and then grows internally. In clients' TFSAs. Great company. Sold SHOP and deployed to this. Makes sense to hold, if it's not too big a weight in your portfolio.

If you're determined to get in now, buy half a position and then look for weakness down the road.

TOP PICK

Very disciplined approach to acquisitions, which they integrate and manage very well. Strong management team. Rights offering raised $280M so they can pay down debt and still have money in their jeans. Tech valuations have come down, so it will be on the hunt for opportunistic acquisitions, which is positive. Yield is 0.19%.

(Analysts’ price target is $3114.38)
PAST TOP PICK
(A Top Pick Oct 12/22, Up 57%)

Exceptional compounder. Difficult business model to replicate. Product risk is exceptionally low because it's so diversified. Have to be disciplined on price, don't buy here. Keep your eye on and add on a pullback.

BUY

A great chart. It will consolidate at some periods, but is now in a leg up, making higher highs.

BUY ON WEAKNESS
Buy rights to the unsecured debentures?

Great business model, management team, and culture. They go quietly about their business. Focused on vertical markets, which is extremely fragmented and the pieces can be bought by a serial acquirer for modest multiples. A friendly buyer, very profitable.

Owns the stock, but doesn't own the debenture rights anymore. Debentures have the advantage of good credit quality plus inflation protection. He didn't want the exposure, so sold the rights.

COMMENT

It has done very well but is maybe overdone, so you could trim your position. It is well positioned in the tech sector but he prefers others with more attractive prices.

COMMENT

It's had a good run. Any uptrend will see a consolidation period which is happening now. Nothing wrong with that. Could pull back slightly. The story is intact long term.

BUY ON WEAKNESS

Great company with strong history of M&A.
Also organic growth recently.
Does not owns shares currently.
Higher interest rates makes funding costs tough.
Wait for pullback before investing.
Quality company for long term investors.
Excellent management team. 

Showing 166 to 180 of 437 entries